Kelly Handley

Kelly Handley is a Senior Medical Statistician at the Birmingham Clinical Trials Unit, University of Birmingham. She specializes in designing and analyzing clinical trials across multiple medical domains.

• Key research areas: Randomized Controlled Trials, Colorectal Cancer, Liver Cirrhosis, Surgical Site Infection
• Active projects include ROSSINI-Platform trials, CALIBRE Trial, and EME-ECAL study

Research trends focus on pragmatic clinical trial methodologies, surgical outcome optimization, and biomarker-driven oncology interventions. Recent work includes international multicenter trials in ulcerative colitis and colorectal stenting.

Publication highlights span gastroenterology, oncology, and cardiology journals, emphasizing evidence-based clinical practice improvements.